Lxwar C 5mg/325mg/10mg Tablet
By Lxwar C
Rx
10 Tablet in a Strip

Composition
Cetirizine(5mg) + Paracetamol(325mg) + Phenylephrine(10mg)

Manufacturer - Lxir Medilabs Pvt Ltd
Sco 48 Sector 5 Mdc Panchkula Haryana 134114 Panchkula - 134114, Haryana, India

Expires on or after
October, 2025

liver
Lxwar C 5mg/325mg/10mg Tablet is considered safe for use in patients with liver disease. Based on the limited data available, it appears that adjusting the dose of Lxwar C 5mg/325mg/10mg Tablet may not be necessary for these patients. It is still advised to consult your doctor before taking this medication to ensure proper guidance and monitoring.

kidney
Lxwar C 5mg/325mg/10mg Tablet should be used carefully if you have kidney disease. Your doctor may need to adjust the dose, so it's important to talk to them. Avoid using if you have severe kidney disease as it can lead to increased drowsiness, especially in patients with end-stage kidney disease.

alcohol
It is not safe to drink alcohol while taking Lxwar C 5mg/325mg/10mg Tablet.

driving
Lxwar C 5mg/325mg/10mg Tablet typically does not impact your driving ability.

pregnancy
Lxwar C 5mg/325mg/10mg Tablet may be unsafe during pregnancy. Limited human studies suggest potential harm to the developing baby, according to animal studies. Consult your doctor to evaluate benefits and risks before use.

breastfeeding
Lxwar C 5mg/325mg/10mg Tablet is likely safe to use while breastfeeding. Limited data indicates low risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹40
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024